Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2018 Nov 1;79(3):339–346. doi: 10.1097/QAI.0000000000001822

Table 4.

Multivariable analyses with PrEP use outcome among BMSM (N=4,184) from multiple US cities.

Variable PrEP Use
aOR (95%CI)
Education .94 (.85–1.01)
Residential instability in past 12 months 3.28 (2.42–4.45)***
Currently have health care coverage? 2.41 (1.64–3.56)***
Tested for HIV in past 6 months 3.83 (2.79–5.25)***
CESD Score 1.00 (0.97–1.02)
Number of male anal sex partners 1.02 (1.01–1.04)***
Condom use during receptive anal sex 1.22 (0.91–1.63)
Condom use during insertive anal sex 1.01 (0.75–1.34)
Any STI 2.43 (1.88–3.15)***
Marijuana 0.89 (0.65–1.20)
Amyl nitrates 1.44 (0.83–2.50)
Stimulants (crack, cocaine, meth, ecstasy) 2.01 (1.18–3.39)*
Erectile dysfunction medications 1.57 (0.74–3.33)
Heroin 0.86 (0.33–2.22)
Opiates 0.76 (0.33–1.74)
Problematic alcohol use (CAGE ≥2) 1.09 (0.81–1.48)

Note: All analyses controlled for city and year of assessment.